GH Research (GHRS) Net Shares Issued and Repurchased (2025)
GH Research's (GHRS) quarterly Net Shares Issued and Repurchased came in at $150.0 million in Q1 2025.
GH Research (GHRS) Net Shares Issued and Repurchased (2025) Analysis & Trends
GH Research's Net Shares Issued and Repurchased history runs 1 years deep, the most recent figure standing at $150.0 million for Q1 2025.
- On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to $150.0 million in Q1 2025; TTM through Dec 2025 was $150.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $150.0 million, changed N/A from the prior year.
- Net Shares Issued and Repurchased held at $150.0 million in Q1 2025 per GHRS's latest filing.
- Across five years, Net Shares Issued and Repurchased topped out at $150.0 million in Q1 2025 and bottomed at $150.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - | - |
| 10 | GH Research | 1.67 Bn | 1.42 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 150.00 Mn |
| Mar 31, 2025 | 150.00 Mn |